Intratympanic dexamethasone for managing pregnant women with sudden hearing loss.
J Int Med Res
; 47(1): 377-382, 2019 Jan.
Article
em En
| MEDLINE
| ID: mdl-30328358
OBJECTIVE: This study aimed to investigate the effect and safety of intratympanic dexamethasone in pregnant women with idiopathic sudden sensorineural hearing loss (ISSNHL). METHODS: We performed a prospective study on pregnant women who suffered from ISSNHL and were treated in our clinic during 2016. The patients received intratympanic treatment three to four times a week. A pure tone audiogram (PTA) was performed before treatment and patients were followed up until 2 months after treatment was finished. RESULTS: A total of six pregnant women were included. All of the patients tolerated intratympanic treatment well. The mean improvement in hearing was 48 ± 7.33 dB. There were no complications, including permanent perforation of the ear drum or middle ear infection. Each patient delivered a healthy newborn. CONCLUSION: Intratympanic dexamethasone is effective and safe for treating pregnant women with ISSNHL. Further randomized, controlled studies on this treatment need to be performed.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Dexametasona
/
Perda Auditiva Súbita
/
Injeção Intratimpânica
/
Glucocorticoides
/
Perda Auditiva Neurossensorial
Idioma:
En
Ano de publicação:
2019
Tipo de documento:
Article